IDiyas

For the Inventor, By the Inventor

Seltisberg, Switzerland

Madhukar Subraya Chodnekar

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 74(Granted Patents)


Location History:

  • Basel, CH (1976 - 1979)
  • Seltisberg, CH (1976 - 1983)

Company Filing History:

goldMedal16 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1983

Loading Chart...
16 patents (USPTO):Explore Patents
1. 4390540 - Imidazoquinazolines having pharmaceutical activity (1983-06-28),
2. 4256748 - Imidazo[2,1-b]quinazolin-2(3H)-ones and pharmaceutical compositions for (1981-03-17),
3. 4234598 - Phenylcarbamates (1980-11-18),
4. 4138579 - Alkynyloxy-phenyl derivatives (1979-02-06),
5. 4059600 - Epoxy dodecadienamides (1977-11-22),
6. 4051319 - Alkynyloxy-phenyl derivatives (1977-09-27),
7. 4027033 - Pesticides (1977-05-31),
8. 4005216 - Phenyl carbamate (1977-01-25),
9. 4002647 - Novel benzofuranyl pest retardants (1977-01-11),
10. 4001339 - Phenyl derivatives (1977-01-04),
11. 3983247 - 2,4-Dodecadienoic acid esters and use for insecticides (1976-09-28),
12. 3966780 - Propargyl esters of 7,11-substituted dodecadienoic acids (1976-06-29),
13. 3957833 - Alkynyloxy-phenyl derivatives (1976-05-18),
14. 3957763 - Phenyl derivatives (1976-05-18),
15. 3946040 - Propynyl benzyl ethers (1976-03-23),

Title: The Innovative Contributions of Madhukar Subraya Chodnekar

Introduction

Madhukar Subraya Chodnekar is a notable inventor based in Seltisberg, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 16 patents to his name, Chodnekar's work has had a profound impact on medical science.

Latest Patents

Chodnekar's latest patents include groundbreaking compounds such as Imidazoquinazolines, which exhibit pharmaceutical activity. These compounds are designed to inhibit the aggregation of blood platelets and gastric acid secretion, showcasing their potential benefits for the circulatory system. Another significant patent involves Imidazo[2,1-b]quinazolin-2(3H)-ones, which are also aimed at preventing thromboses and treating cardiac insufficiency without causing substantial tachycardia.

Career Highlights

Chodnekar is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to further his research and development efforts in creating effective therapeutic agents.

Collaborations

Throughout his career, Chodnekar has collaborated with esteemed colleagues such as Ulrich Schwieter and Albert Pfiffner. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Madhukar Subraya Chodnekar's innovative work in pharmaceuticals has led to the development of important therapeutic agents. His contributions continue to influence the medical field, demonstrating the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…